Serving people from the Boundary, Cariboo, Kootenay, Okanagan, Similkameen and Thompson regions of B.C., patients at BC Cancer – Kelowna have access to assessment and diagnostic services, chemotherapy, radiation therapy and supportive care. Patients can also take part in clinical trials and specific initiatives that are vital to the centre’s research programs.

To continue to propel leading-edge innovation in brachytherapy at BC Cancer – Kelowna and ensure patients in the Interior continue to have access to world-class care, the Foundation has embarked on a $3.5 million fundraising initiative to establish a Chair in Brachytherapy at the centre.

At BC Cancer – Kelowna, the centre is recognized for: 

  • Being provincial leaders in high dose rate (HDR) brachytherapy for breast, prostate and gynecological cancers, having changed standard of care
  • Developing computer software to improve radiation treatment
  • Providing a robust patient and family comfort program to enhance care

HDR Brachytherapy

Brachytherapy is widely used to treat various types of cancer. The term brachytherapy refers to the placement of radioactive "seeds" or "sources" inside or next to a tumour. The seeds/sources deliver radiation directly to the tumour, sparing surrounding healthy tissue. Some patients experience fewer side effects because healthy tissue is not dramatically affected by brachytherapy. Sometimes brachytherapy is used instead of surgery.

HDR (high dose-rate) Brachytherapy treatment is very different from permanent seed implants and is more versatile and precise, where no radioactivity is left in the patient, but instead a very high intensity radioactive source is used to traverse the tumour under ultrasound guidance.

With thanks to critical donor funds, radiation therapists at BC Cancer – Kelowna have a specific HDR Brachytherapy operating facility, enabling the team to see more patients and administer an increased number of low dose rate permanent seed brachytherapy implants, but also begin new programs and clinical trials. The team is a leader in HDR Brachytherapy in the country for breast, prostate and gynecological cancers, and has changed the standard of care.

You can support BC Cancer - Kelowna


For more information, contact:

Pardeep Khrod
Executive Director
PH: 250.878.5490